000 01053 a2200301 4500
005 20250513155600.0
264 0 _c19990211
008 199902s 0 0 eng d
022 _a0085-2538
024 7 _a10.1046/j.1523-1755.1998.001711.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFogo, A B
245 0 0 _aCompound interest: ACE and PAI-1 polymorphisms and risk of thrombosis and fibrosis.
_h[electronic resource]
260 _bKidney international
_cNov 1998
300 _a1765-6 p.
_bdigital
500 _aPublication Type: Editorial
650 0 4 _aFibrosis
650 0 4 _aHumans
650 0 4 _aPeptidyl-Dipeptidase A
_xgenetics
650 0 4 _aPlasminogen Activator Inhibitor 1
_xgenetics
650 0 4 _aPolymorphism, Genetic
650 0 4 _aRenin-Angiotensin System
_xphysiology
650 0 4 _aRisk
650 0 4 _aThrombosis
_xetiology
700 1 _aVaughan, D E
773 0 _tKidney international
_gvol. 54
_gno. 5
_gp. 1765-6
856 4 0 _uhttps://doi.org/10.1046/j.1523-1755.1998.001711.x
_zAvailable from publisher's website
999 _c9807329
_d9807329